Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1980-5-23
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0021-5198
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
29
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
303-6
|
| pubmed:dateRevised |
2003-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:537252-Analgesics,
pubmed-meshheading:537252-Animals,
pubmed-meshheading:537252-Anti-Inflammatory Agents,
pubmed-meshheading:537252-Male,
pubmed-meshheading:537252-Mice,
pubmed-meshheading:537252-Morpholines,
pubmed-meshheading:537252-Pyridazines,
pubmed-meshheading:537252-Rats,
pubmed-meshheading:537252-Structure-Activity Relationship
|
| pubmed:year |
1979
|
| pubmed:articleTitle |
Pharmacological investigations of 4-alkoxy-2-methyl-5-morpholino-3(2H)-pyridazinone derivatives.
|
| pubmed:publicationType |
Journal Article
|